duloxetine hydrochloride has been researched along with Depression in 113 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 33 (29.20) | 29.6817 |
| 2010's | 62 (54.87) | 24.3611 |
| 2020's | 18 (15.93) | 2.80 |
| Authors | Studies |
|---|---|
| Hoffmann, M; Niedrig, DF; Russmann, S | 1 |
| Chen, Y; Liang, L; Ren, X; Xiong, J; Zhang, G | 1 |
| Oda, Y; Sato, A; Shimizu, T; Shimoda, K; Shinozaki, M; Suzuki, Y; Yang, M; Yasui-Furukori, N | 1 |
| Chen, J; Zhang, K; Zhu, J | 1 |
| Cao, J; Ding, ZC; Huang, C; Li, H; Wang, HY; Yuan, MC; Zhou, ZK | 1 |
| Ikenouchi, A; Okamoto, N; Yoshimura, R | 1 |
| Cao, Q; Rao, Y; Yang, R; Zhao, J | 1 |
| Chen, H; He, Y; Li, J; Li, L; Su, H; Su, S; Wang, T; Yang, P | 1 |
| Hadryś, T; Machowska, M; Maciaszek, J; Misiak, B; Pawłowski, T; Wiela-Hojeńska, A | 1 |
| Eriksson, E; Hieronymus, F; Lisinski, A; Näslund, J; Nilsson, S | 1 |
| Kociszewski, J; Poleszak, E; Serefko, A; Szopa, A; Wiśniewski, R; Woźniak, A; Wróbel, A | 1 |
| Nagamine, T | 1 |
| Baumgartner, M; Kuzin, M; Nolan, D; Paulzen, M; Scharrer, I; Schoretsanitis, G; Xepapadakos, F | 1 |
| Djordjevic, JD; Jasnic, NI; Micov, AM; Pecikoza, UB; Stepanović-Petrović, RM; Todorović, MB; Tomić, MA; Vuković, MJ | 1 |
| Edwards, RR; Hunter, DJ; Katz, JN; Lenhard, NK; Losina, E; Neogi, T; Ross, EL; Song, S; Sullivan, JK | 1 |
| Dahiya, L; Kumar, R; Sarwal, A; Sinha, VR | 1 |
| Abe, T; Furukawa, TA; Iwanami, A; Mimura, M; Nakagawa, A; Nakagome, K; Nishioka, G; Tani, M; Watanabe, K; Yokoi, Y; Yoshimura, N | 1 |
| Becker, T; Breilmann, J; Kösters, M; Reuter, B; Schneider, C | 1 |
| Rechberger, E; Rechberger, T; Wróbel, A | 1 |
| Jiao, Y; Liang, Y; Lin, J; Qu, H; Sun, Y; Xu, J; Zhao, C | 1 |
| Blasco-Serra, A; Cervera-Ferri, A; González-Soler, EM; Teruel-Martí, V; Valverde-Navarro, AA | 1 |
| Ali, J; Baboota, S; Iqbal, B; Kumar, S; Sindhu, P | 1 |
| Beyer, JL; Johnson, KG | 1 |
| Esumi, S; Kawasaki, Y; Kitamura, Y; Nagai, R; Ogawa, A; Sendo, T; Ushio, S; Yamada-Takemoto, A; Yokota-Kumasaki, H | 1 |
| Duan, LP; Jiang, RH; Liu, YX; Liu, ZJ; Wang, K; Wang, XQ; Wang, Z; Zhang, JJ; Zhang, L; Zhu, HQ; Zhu, SW | 1 |
| Bidari, A; Ghavidel-Parsa, B; Hassankhani, A; Hosseini, S; Moazen-Zadeh, E; Rahmani, S | 1 |
| Cipriani, A; Furukawa, TA; Ikeda, K; Imai, H; Maruo, K; Noma, H; Shinohara, K; Tanaka, S; Yamawaki, S | 1 |
| Assié, MB; Auclair, AL; Bardin, L; Cussac, D; Depoortère, R; Heusler, P; Marien, M; Martel, JC; Newman-Tancredi, A; O'Connor, JA | 1 |
| Chen, W; Geng, Y; Hu, XY; Wei, LL; Yao, LY; Zhang, JH; Zhang, LS | 1 |
| Berk, M; Dodd, S; Kelin, K; Mancini, M; Schacht, A | 1 |
| Bussone, G; Curone, M; D'Amico, D; Proietti-Cecchini, A; Savino, M; Tullo, V | 1 |
| Gazerani, P; Johansen, AN; Rosenzweig, M; Stenzhorn, AA; Thirstrup, S | 1 |
| DU, XN; Huang, F; Huang, ZF; Li, Y; Zhang, SL; Zhu, J | 1 |
| Itoh, M; Masuda, R; Suzuki, T | 1 |
| Bech, BH; Christensen, J; Kjaersgaard, MI; Olsen, J; Parner, ET; Pedersen, LH; Sørensen, MJ; Vestergaard, M | 1 |
| Anjum, MW; Bradley, KC; Gebeline-Myers, C; Young, WB | 1 |
| Akbudak, M; Belli, H; Ural, C | 1 |
| Alam, MY; Chen, Y; Jacobsen, PL; Mahableshwarkar, AR; Serenko, M | 1 |
| Corrigan, PW; Fokuo, JK; Kosyluk, KA; Park, JH | 1 |
| Hou, YC; Lai, CH | 1 |
| Boyce, P; Gorwood, P; Picard, H; Schacht, A; Schaffer, A | 1 |
| De Berardis, D; De Pasquale, C; Fornaro, M; Fornaro, P; Iasevoli, F; Martino, M; Mattei, C; Mungo, S; Prestia, D; Vinciguerra, V | 1 |
| Gramec, D; Peterlin Mašič, L; Sollner Dolenc, M | 1 |
| Berk, M; Craig Nelson, J; Deberdt, W; Dodd, S; Eriksson, E; Kelin, K; Zhang, Q | 1 |
| Berggren, L; Gilaberte, I; Lenox-Smith, A; Pérez, V; Quail, D; Romera, I | 1 |
| Andrade, C | 1 |
| Arulpragasam, AR; Chou, T; Corse, AK; Deckersbach, T; Dougherty, DD; Duffy, A; Jenike, MA; Keuthen, NJ | 1 |
| Ball, SG; Escobar, R; Lipsius, S | 1 |
| Berggren, L; Fujikoshi, S; Harada, E; Kato, M; Tokuoka, H; Wohlreich, MM | 1 |
| Bouhassira, D; Choy, E; Cruccu, G; Freynhagen, R; Kosek, E; Lenox-Smith, A; Lledó, A; Marchettini, P; Micó, JA; Perrot, S; Petto, H; Skljarevski, V; Späth, M; Tesfaye, S; Tölle, T; Wilhelm, S | 1 |
| Chang, CL; Dore, DD; Li, H; Lin, ND; Norman, H; Perahia, DG; Regev, A | 1 |
| Blum, LM; Scanlon, KA; Starkey, SJ; Stoppacher, R | 1 |
| Liu, Y; Pan, B | 1 |
| Ceci, A; Doods, H; Hu, B; Treede, RD | 1 |
| Fan, QY; Fan, SY; He, XH; Li, J; Li, Y; Li, YF; Xue, R; Zhang, TT; Zhang, YZ; Zhong, BH | 1 |
| Girbovan, A; Legriel, S; Marquion, F; Merceron, S; Muret, A; Palette, C; Perier, F; Pico, F; Zappella, N | 1 |
| Gulinello, M; Li, Y; Sanchez, C | 1 |
| Fan, SY; He, XH; Jin, ZL; Li, NM; Li, Y; Li, YF; Xue, R; Yuan, L; Zhang, TT; Zhang, YZ; Zheng, AP; Zhong, BH | 1 |
| Chappell, AS; Detke, MJ; Kajdasz, DK; Mease, PJ; Russell, IJ; Walker, DJ; Wiltse, CG; Wohlreich, MM | 1 |
| Brister, JC; Reeves, RR | 1 |
| Chang, JP; Lane, HY; Su, KP; Tsai, CH; Wu, PL | 1 |
| Berrocoso, E; Mico, JA | 1 |
| Ememlin, AIu; Kashin, AV; Odinak, MM | 1 |
| Alda, M; Andrés, E; del Hoyo, YL; García-Campayo, J; Luciano, JV; Magallón, R; Rodero, B; Serrano-Blanco, A | 1 |
| Chiocchetti, B; Melani, F; Muscas, GC; Rosati, E | 1 |
| Basu, M; Duckett, JR | 1 |
| Bennett, RM; Chappell, AS; Collins, H; Iyengar, S; Li, LC; Liu-Seifert, H; Ossanna, MJ; Skljarevski, V | 1 |
| Lai, CH | 1 |
| Bhatt, PA; Chudasama, HP | 1 |
| Brahm, NC; Crosby, KM; Stovall, R | 1 |
| Aung, GL; Kawamoto, LS; O'Brien, JG; Tien, PG | 1 |
| Harnett-Sheehan, K; Prakash, A; Sheehan, DV; Spann, ME; Thompson, HF | 1 |
| Benedetto, E; Harris, SS; Kushon, D | 1 |
| Bitter, I; Czobor, P; Filipovits, D | 1 |
| Ahl, J; Arnold, LM; Gaynor, PJ; Wang, F; Wohlreich, MM | 1 |
| Seeger, JD; Strombom, I; Turnbull, B; Xue, F; Zhu, S | 1 |
| Bandini, F; Cestari, L; Colicchio, S; Cordano, C; Escelsior, A; Fornaro, M; Martino, M; Ogliastro, C; Perugi, G; Rocchi, G | 1 |
| Capasso, A; Caputo, M; Monteleone, F; Tecce, MF | 1 |
| Hegerl, U; Hundemer, HP; Linden, M; Quail, D; Schneider, E; Wagner, T; Weigmann, H | 1 |
| Jan, KA; Kao, JT; Lin, SJ | 1 |
| Ikeda, K; Kobayashi, T; Washiyama, K | 1 |
| Nagarsenker, M; Padhye, S; Patel, K | 1 |
| Baker, RA; Bennetts, JS; Cardinal, T; Tully, PJ | 1 |
| Bose, A; Li, D; Tsai, J | 1 |
| Boess, FG; Hegerl, U; Linden, M; Mergl, R; Schacht, A; Schneider, E; Wilhelm, S | 1 |
| Karaiskos, D; Paparrigopoulos, T; Spengos, K; Tzavellas, E; Vassilopoulou, S | 1 |
| Barbui, C; Cipriani, A; Furukawa, TA; Koesters, M; Nosè, M; Omori, IM; Purgato, M; Trespidi, C | 1 |
| Bahin, FF; Chu, G; Rhodes, G | 1 |
| Assisi, AP; Fedullo, F; Gianni, W; Modestino, A; Scuteri, A | 1 |
| Pae, CU | 1 |
| Detke, MJ; Dunner, DL; Goldstein, DJ; Lu, Y; Mallinckrodt, C | 1 |
| Littlejohn, GO | 1 |
| Bymaster, FP; Detke, MJ; Iyengar, S; Knadler, MP; Lee, TC | 1 |
| Detke, MJ; Goldstein, DJ; Iyengar, S; Lee, TC; Lu, Y | 1 |
| Marcil, WA; Petty, F | 1 |
| Bauer, M; Möller, HJ; Schneider, E | 1 |
| Maramattom, BV | 1 |
| Friede, T; Kieser, M | 1 |
| Viktrup, L; Yalcin, I | 1 |
| Forscher, CA; Kerrihard, TN; Strouse, TB; Zakowski, P | 1 |
| Hajak, G | 1 |
| Pitchot, W | 1 |
| Aubry, JM; Barbe, R; Bertschy, G; Bryois, C; Delini-Stula, A; Gervasoni, N; Merlo, M | 1 |
| Dirks, AC; van Hyfte, DM | 1 |
| Amore, M; Cazzolla, R; Mandrioli, R; Mercolini, L; Raggi, MA | 1 |
| Bria, P; Catalano, V; Harnic, D; Janiri, L; Mazza, M | 1 |
| Andreotti, C; Fava, M; Lohr, J; O'Reardon, JP; Perlis, RH; Petersen, T; Solvason, HB; Ticknor, C; Wilson, M; Wohlreich, MM | 1 |
| Brannan, SK; Desaiah, D; Detke, MJ; Ossanna, MJ; Pritchett, YL; Trivedi, MH | 1 |
| Blier, P; de Montigny, C; Debonnel, G; Hébert, C; Turcotte, JE | 1 |
20 review(s) available for duloxetine hydrochloride and Depression
| Article | Year |
|---|---|
Efficacy and tolerability of antidepressant drugs in treatment of depression in children and adolescents: a network meta-analysis.
Topics: Adolescent; Amitriptyline; Antidepressive Agents; Child; Depression; Depressive Disorder, Major; Duloxetine Hydrochloride; Escitalopram; Fluoxetine; Humans; Imipramine; Network Meta-Analysis; Paroxetine; Sertraline; Venlafaxine Hydrochloride | 2022 |
Item-based analysis of the effects of duloxetine in depression: a patient-level post hoc study.
Topics: Antidepressive Agents; Clinical Trials as Topic; Depression; Duloxetine Hydrochloride; Humans; Psychiatric Status Rating Scales; Treatment Outcome | 2020 |
Systematic evaluation of the 'efficacy-effectiveness gap' in the treatment of depression with venlafaxine and duloxetine.
Topics: Antidepressive Agents; Depression; Duloxetine Hydrochloride; Humans; Prospective Studies; Venlafaxine Hydrochloride | 2021 |
Advances in Pharmacotherapy of Late-Life Depression.
Topics: Antidepressive Agents; Aripiprazole; Depression; Depressive Disorder; Drug Resistance; Duloxetine Hydrochloride; Humans; Paroxetine; Quetiapine Fumarate; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Sertraline; Vortioxetine | 2018 |
Exploratory analyses of effect modifiers in the antidepressant treatment of major depression: Individual-participant data meta-analysis of 2803 participants in seven placebo-controlled randomized trials.
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Citalopram; Depression; Depressive Disorder, Major; Double-Blind Method; Duloxetine Hydrochloride; Female; Humans; Japan; Male; Middle Aged; Mirtazapine; Paroxetine; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Treatment Outcome; Venlafaxine Hydrochloride | 2019 |
Treatment response for acute depression is not associated with number of previous episodes: lack of evidence for a clinical staging model for major depressive disorder.
Topics: Acute Disease; Adult; Antidepressive Agents; Citalopram; Cyclohexanols; Depression; Depressive Disorder, Major; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Paroxetine; Recurrence; Thiophenes; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride | 2013 |
Depression symptom clusters and their predictive value for treatment outcomes: results from an individual patient data meta-analysis of duloxetine trials.
Topics: Clinical Trials as Topic; Cluster Analysis; Databases, Factual; Depression; Duloxetine Hydrochloride; Female; Humans; Male; Predictive Value of Tests; Selective Serotonin Reuptake Inhibitors; Thiophenes; Treatment Outcome | 2014 |
Bioactivation potential of thiophene-containing drugs.
Topics: Antidepressive Agents; Cytochrome P-450 Enzyme System; Depression; Duloxetine Hydrochloride; Hepatitis; Humans; Platelet Aggregation Inhibitors; Thiophenes; Ticrynafen | 2014 |
Application of the Gradient Boosted method in randomised clinical trials: Participant variables that contribute to depression treatment efficacy of duloxetine, SSRIs or placebo.
Topics: Adult; Aged; Depression; Depressive Disorder; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Randomized Controlled Trials as Topic; Regression Analysis; Selective Serotonin Reuptake Inhibitors; Thiophenes; Treatment Outcome | 2014 |
Update on duloxetine for the management of stress urinary incontinence.
Topics: Depression; Duloxetine Hydrochloride; Female; Humans; Nervous System; Selective Serotonin Reuptake Inhibitors; Thiophenes; United Kingdom; Urinary Bladder, Overactive; Urinary Incontinence, Stress; Urinary Tract | 2009 |
Adverse reactions to duloxetine in depression.
Topics: Animals; Antidepressive Agents; Depression; Duloxetine Hydrochloride; Humans; Randomized Controlled Trials as Topic; Thiophenes; Treatment Outcome | 2011 |
Duloxetine in the treatment of depression: an overview.
Topics: Animals; Antidepressive Agents; Depression; Duloxetine Hydrochloride; Humans; Psychotherapy; Thiophenes | 2011 |
Duloxetine versus other anti-depressive agents for depression.
Topics: Antidepressive Agents; Citalopram; Cyclohexanols; Depression; Desvenlafaxine Succinate; Dibenzothiazepines; Duloxetine Hydrochloride; Fluoxetine; Humans; Paroxetine; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Thiophenes; Venlafaxine Hydrochloride | 2012 |
Balanced treatments for fibromyalgia.
Topics: Biogenic Monoamines; Depression; Duloxetine Hydrochloride; Fibromyalgia; Humans; Neurotransmitter Uptake Inhibitors; Pain Threshold; Thiophenes | 2004 |
The dual transporter inhibitor duloxetine: a review of its preclinical pharmacology, pharmacokinetic profile, and clinical results in depression.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Depression; Depressive Disorder, Major; Duloxetine Hydrochloride; Humans; Microdialysis; Selective Serotonin Reuptake Inhibitors; Thiophenes | 2005 |
Duloxetine: a new selective and dual-acting antidepressant.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Depression; Drug Evaluation, Preclinical; Duloxetine Hydrochloride; Humans; Pain; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Thiophenes; Treatment Outcome | 2006 |
[Dual acting reuptake inhibitors in the treatment of depression and pain].
Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Chronic Disease; Depression; Diabetes Complications; Diabetes Mellitus, Type 2; Duloxetine Hydrochloride; Humans; Norepinephrine; Pain; Selective Serotonin Reuptake Inhibitors; Serotonin; Thiophenes; Treatment Outcome | 2006 |
[Medication of the month. Duloxetine (Cymbalta)].
Topics: Antidepressive Agents; Depression; Duloxetine Hydrochloride; Humans; Thiophenes | 2006 |
[Psychiatry].
Topics: Adolescent; Antidepressive Agents; Bipolar Disorder; Child; Depression; Duloxetine Hydrochloride; Humans; Mental Disorders; Schizophrenia; Thiophenes | 2007 |
Clinical evidence for serotonin and norepinephrine reuptake inhibition of duloxetine.
Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Depression; Duloxetine Hydrochloride; Evidence-Based Medicine; Humans; Norepinephrine Plasma Membrane Transport Proteins; Selective Serotonin Reuptake Inhibitors; Thiophenes; Treatment Outcome | 2008 |
28 trial(s) available for duloxetine hydrochloride and Depression
| Article | Year |
|---|---|
Significant Analgesic Benefits of Perioperative Duloxetine in Patients Who Have Depressive Symptoms Undergoing Total Hip Arthroplasty: A Randomized Controlled Trial.
Topics: Analgesics; Analgesics, Opioid; Arthroplasty, Replacement, Hip; Depression; Double-Blind Method; Duloxetine Hydrochloride; Humans; Morphine; Pain, Postoperative; Treatment Outcome | 2023 |
Acceptability of escitalopram versus duloxetine in outpatients with depression who did not respond to initial second-generation antidepressants: A randomized, parallel-group, non-inferiority trial.
Topics: Antidepressive Agents; Citalopram; Depression; Depressive Disorder, Major; Duloxetine Hydrochloride; Humans; Japan; Outpatients; Treatment Outcome | 2021 |
Comparing duloxetine and pregabalin for treatment of pain and depression in women with fibromyalgia: an open-label randomized clinical trial.
Topics: Adult; Chronic Pain; Depression; Drug Administration Schedule; Duloxetine Hydrochloride; Female; Fibromyalgia; Humans; Medication Adherence; Middle Aged; Pregabalin; Treatment Outcome; Young Adult | 2019 |
Prophylactic effects of duloxetine on post-stroke depression symptoms: an open single-blind trial.
Topics: Aged; Antidepressive Agents; Depression; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Single-Blind Method; Stroke; Thiophenes | 2013 |
Outcome of patients with chronic migraine with medication overuse and depression after duloxetine: influence of coexisting obsessive compulsive disorder.
Topics: Adult; Aged; Analgesics; Depression; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Migraine Disorders; Obsessive-Compulsive Disorder; Substance-Related Disorders; Thiophenes; Treatment Outcome; Young Adult | 2013 |
[Impact of duloxetine on depression and anxiety in patients with ankylosing spondylitis: a case-control study].
Topics: Adult; Analgesics; Antidepressive Agents; Anxiety; Depression; Duloxetine Hydrochloride; Female; Humans; Male; Pain; Spondylitis, Ankylosing; Thiophenes; Young Adult | 2013 |
Safety, tolerability, and efficacy of vortioxetine (Lu AA21004) in major depressive disorder: results of an open-label, flexible-dose, 52-week extension study.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Anxiety; Depression; Depressive Disorder, Major; Double-Blind Method; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Sexual Dysfunction, Physiological; Suicidal Ideation; Sulfides; Thiophenes; Treatment Outcome; Vortioxetine; Weight Gain; Young Adult | 2014 |
How does direct to consumer advertising affect the stigma of mental illness?
Topics: Adult; Advertising; Attitude to Health; Depression; Duloxetine Hydrochloride; Female; Humans; Male; Mental Disorders; Psychotropic Drugs; Stereotyping; Surveys and Questionnaires; Thiophenes | 2014 |
Duloxetine-bupropion combination for treatment-resistant atypical depression: a double-blind, randomized, placebo-controlled trial.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Bupropion; Depression; Double-Blind Method; Drug Therapy, Combination; Duloxetine Hydrochloride; Female; Follow-Up Studies; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Thiophenes; Young Adult | 2014 |
Open-label study of duloxetine for the treatment of obsessive-compulsive disorder.
Topics: Adolescent; Adult; Anxiety; Depression; Duloxetine Hydrochloride; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neurotransmitter Uptake Inhibitors; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Psychotropic Drugs; Quality of Life; Thiophenes; Treatment Outcome; Young Adult | 2015 |
Validation of the geriatric anxiety inventory in a duloxetine clinical trial for elderly adults with generalized anxiety disorder.
Topics: Aged; Aged, 80 and over; Antidepressive Agents; Anxiety; Anxiety Disorders; Argentina; Austria; Canada; Depression; Double-Blind Method; Duloxetine Hydrochloride; Female; Germany; Humans; Male; Mexico; Poland; Psychiatric Status Rating Scales; Psychometrics; Reproducibility of Results; Spain; Treatment Outcome; United Kingdom; United States | 2015 |
Changes in energy during treatment of depression: an analysis of duloxetine in double-blind placebo-controlled trials.
Topics: Antidepressive Agents; Depression; Dose-Response Relationship, Drug; Double-Blind Method; Duloxetine Hydrochloride; Energy Metabolism; Female; Follow-Up Studies; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Severity of Illness Index; Treatment Outcome | 2015 |
Are there different predictors of analgesic response between antidepressants and anticonvulsants in painful diabetic neuropathy?
Topics: Affect; Age Factors; Aged; Analgesics; Anticonvulsants; Antidepressive Agents; Anxiety; Depression; Diabetic Neuropathies; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Pain; Pregabalin; Psychiatric Status Rating Scales; Treatment Outcome | 2016 |
Long-term safety, tolerability, and efficacy of duloxetine in the treatment of fibromyalgia.
Topics: Antidepressive Agents; Depression; Disability Evaluation; Double-Blind Method; Duloxetine Hydrochloride; Female; Fibromyalgia; Health Status; Humans; Male; Middle Aged; Pain; Pain Measurement; Thiophenes; Treatment Outcome | 2010 |
[Cymbalta in the treatment of chronic pain syndromes].
Topics: Adult; Antidepressive Agents; Chronic Disease; Depression; Duloxetine Hydrochloride; Follow-Up Studies; Humans; Middle Aged; Pain; Pain Measurement; Syndrome; Thiophenes; Treatment Outcome | 2009 |
Effectiveness of the psychological and pharmacological treatment of catastrophization in patients with fibromyalgia: a randomized controlled trial.
Topics: Adolescent; Adult; Aged; Analgesics; Antidepressive Agents; Cognitive Behavioral Therapy; Combined Modality Therapy; Depression; Duloxetine Hydrochloride; Fibromyalgia; gamma-Aminobutyric Acid; Humans; Middle Aged; Pain; Pain Management; Pain Measurement; Pregabalin; Psychiatric Status Rating Scales; Research Design; Spain; Thiophenes; Time Factors; Treatment Outcome; Young Adult | 2009 |
Duloxetine, a centrally acting analgesic, in the treatment of patients with osteoarthritis knee pain: a 13-week, randomized, placebo-controlled trial.
Topics: Aged; Analgesics; Antidepressive Agents; Depression; Double-Blind Method; Duloxetine Hydrochloride; Female; Humans; Knee; Male; Middle Aged; Osteoarthritis; Pain; Pain Measurement; Psychiatric Status Rating Scales; Thiophenes; Treatment Outcome | 2009 |
Assessing remission in major depressive disorder and generalized anxiety disorder clinical trials with the discan metric of the Sheehan disability scale.
Topics: Antidepressive Agents; Anxiety Disorders; Comorbidity; Depression; Depressive Disorder, Major; Double-Blind Method; Duloxetine Hydrochloride; Humans; Outpatients; Placebos; Psychiatric Status Rating Scales; Psychometrics; Thiophenes; Time Factors; Treatment Outcome | 2011 |
Improvement in multiple dimensions of fatigue in patients with fibromyalgia treated with duloxetine: secondary analysis of a randomized, placebo-controlled trial.
Topics: Adult; Antidepressive Agents; Anxiety; Depression; Duloxetine Hydrochloride; Fatigue; Female; Fibromyalgia; Humans; Male; Middle Aged; Motor Activity; Musculoskeletal Pain; Pain Threshold; Patient Satisfaction; Placebos; Sleep Wake Disorders; Thiophenes; Treatment Outcome | 2011 |
Early reduction in painful physical symptoms is associated with improvements in long-term depression outcomes in patients treated with duloxetine.
Topics: Antidepressive Agents; Depression; Duloxetine Hydrochloride; Female; Humans; International Classification of Diseases; Male; Middle Aged; Outpatients; Pain; Pain Measurement; Prospective Studies; Severity of Illness Index; Thiophenes | 2011 |
Early non-response in patients with severe depression: escitalopram up-titration versus switch to duloxetine.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Citalopram; Depression; Dopamine Uptake Inhibitors; Double-Blind Method; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Severity of Illness Index; Thiophenes; Treatment Outcome; Young Adult | 2012 |
Duloxetine versus citalopram and sertraline in the treatment of poststroke depression, anxiety, and fatigue.
Topics: Activities of Daily Living; Adult; Aged; Antidepressive Agents; Anxiety; Citalopram; Depression; Duloxetine Hydrochloride; Fatigue; Female; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Sertraline; Stroke; Thiophenes; Time Factors; Treatment Outcome; Young Adult | 2012 |
Depression treatment selectively modifies arterial stiffness in older participants.
Topics: Aged; Aging; Antidepressive Agents; Antidepressive Agents, Second-Generation; Blood Pressure; Cardiovascular Diseases; Cholesterol, LDL; Citalopram; Depression; Duloxetine Hydrochloride; Follow-Up Studies; Humans; Pulse Wave Analysis; Thiophenes; Treatment Outcome; Vascular Stiffness | 2013 |
Duloxetine in treatment of anxiety symptoms associated with depression.
Topics: Adult; Antidepressive Agents; Anxiety; Depression; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Drug Administration Schedule; Duloxetine Hydrochloride; Female; Humans; Male; Severity of Illness Index; Surveys and Questionnaires; Thiophenes | 2003 |
Duloxetine vs. placebo in patients with painful diabetic neuropathy.
Topics: Aged; Demography; Depression; Diabetic Neuropathies; Dose-Response Relationship, Drug; Double-Blind Method; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Pain Measurement; Personality Inventory; Placebos; Selective Serotonin Reuptake Inhibitors; Thiophenes; Treatment Outcome | 2005 |
Duloxetine for premenstrual dysphoric disorder: a pilot study.
Topics: Adrenergic Uptake Inhibitors; Adult; Affect; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Depression; Duloxetine Hydrochloride; Female; Humans; Pilot Projects; Premenstrual Syndrome; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Thiophenes; Time Factors; Treatment Outcome | 2008 |
Efficacy of duloxetine for the treatment of depression: relationship to most recent antidepressant trial.
Topics: Adult; Antidepressive Agents; Depression; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Thiophenes | 2008 |
Assessment of the serotonin and norepinephrine reuptake blocking properties of duloxetine in healthy subjects.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Blood Pressure; Brain; Brain Chemistry; Clomipramine; Depression; Dose-Response Relationship, Drug; Duloxetine Hydrochloride; Humans; Male; Norepinephrine; Reference Values; Selective Serotonin Reuptake Inhibitors; Serotonin; Thiophenes; Tyramine | 2001 |
65 other study(ies) available for duloxetine hydrochloride and Depression
| Article | Year |
|---|---|
Severe CNS depression with duloxetine, ciprofloxacin and CYP2D6 deficiency-role and recognition of drug-drug-gene interactions.
Topics: Ciprofloxacin; Cytochrome P-450 CYP2D6; Depression; Drug Interactions; Duloxetine Hydrochloride; Humans | 2022 |
The Potential Antidepressant Action of Duloxetine Co-Administered with the TAAR1 Receptor Agonist SEP-363856 in Mice.
Topics: Animals; Antidepressive Agents; Depression; Duloxetine Hydrochloride; Hindlimb Suspension; Mice; Pyrans; Swimming | 2022 |
Asymptomatic syndrome of inappropriate secretion of antidiuretic hormone (SIADH) following duloxetine treatment for pain with depression: Two case reports.
Topics: Aged; Aged, 80 and over; Depression; Duloxetine Hydrochloride; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Mianserin; Pain; Venlafaxine Hydrochloride | 2022 |
Clinical effect of flunarizine combined with duloxetine in the treatment of chronic migraine comorbidity of depression and anxiety disorder.
Topics: Anxiety; Anxiety Disorders; C-Reactive Protein; Comorbidity; Depression; Duloxetine Hydrochloride; Flunarizine; Humans; Interleukin-6; Migraine Disorders; Tumor Necrosis Factor-alpha | 2022 |
Duloxetine Does not Affect Vascular Endothelial Growth Factor Plasma Levels in Patients with First-Episode, Drug-Naïve Major Depression.
Topics: Depression; Depressive Disorder, Major; Duloxetine Hydrochloride; Humans; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2023 |
Electroacupuncture attenuates chronic inflammatory pain and depression comorbidity by inhibiting hippocampal neuronal apoptosis via the PI3K/Akt signaling pathway.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Chronic Pain; Comorbidity; Depression; Duloxetine Hydrochloride; Electroacupuncture; Hippocampus; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Signal Transduction | 2023 |
The Impact of the CYP2D6 and CYP1A2 Gene Polymorphisms on Response to Duloxetine in Patients with Major Depression.
Topics: Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2D6; Depression; Depressive Disorder, Major; Drug-Related Side Effects and Adverse Reactions; Duloxetine Hydrochloride; Humans; Polymorphism, Genetic | 2023 |
Duloxetine reverses the symptoms of overactive bladder co-existing with depression via the central pathways.
Topics: Acetanilides; Animals; Antidepressive Agents; Behavior, Animal; Corticosterone; Depression; Disease Models, Animal; Duloxetine Hydrochloride; Female; Locomotion; Rats; Rats, Wistar; Signal Transduction; Solifenacin Succinate; Thiazoles; Treatment Outcome; Urinary Bladder, Overactive; Urological Agents | 2020 |
Duloxetine, a serotonin and norepinephrine reuptake inhibitor, may be a double-edged sword for patients with advanced Parkinson's disease.
Topics: Aged; Depression; Duloxetine Hydrochloride; Dyskinesia, Drug-Induced; Humans; Male; Parkinson Disease; Serotonin and Noradrenaline Reuptake Inhibitors | 2020 |
The role of the poor metabolizer genotype CYP2D6 and CYP1A2 phenotype in the pharmacokinetics of duloxetine and venlafaxine-A case report.
Topics: Activation, Metabolic; Adult; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2D6; Depression; Drug Monitoring; Duloxetine Hydrochloride; Female; Genotype; Humans; Inactivation, Metabolic; Pharmacogenetics; Pharmacogenomic Variants; Serotonin and Noradrenaline Reuptake Inhibitors; Venlafaxine Hydrochloride | 2020 |
Vortioxetine reduces pain hypersensitivity and associated depression-like behavior in mice with oxaliplatin-induced neuropathy.
Topics: Animals; Antidepressive Agents; Antineoplastic Agents; Behavior, Animal; Brain Stem; Depression; Dose-Response Relationship, Drug; Duloxetine Hydrochloride; Hyperalgesia; Male; Mice; Mice, Inbred C57BL; Norepinephrine; Oxaliplatin; Pain Measurement; Peripheral Nervous System Diseases; Serotonin; Swimming; Vortioxetine | 2020 |
Does Screening for Depressive Symptoms Help Optimize Duloxetine Use in Knee Osteoarthritis Patients With Moderate Pain? A Cost-Effectiveness Analysis.
Topics: Cost-Benefit Analysis; Depression; Duloxetine Hydrochloride; Humans; Osteoarthritis, Knee; Pain | 2022 |
Transdermal delivery of duloxetine-sulfobutylether-β-cyclodextrin complex for effective management of depression.
Topics: Administration, Cutaneous; Animals; beta-Cyclodextrins; Depression; Duloxetine Hydrochloride; Rats; Rats, Wistar; Skin; Skin Absorption; Transdermal Patch | 2021 |
The influence of duloxetine on detrusor overactivity in rats with depression induced by 13-cis-retinoic acid.
Topics: Animals; Antidepressive Agents; Depression; Duloxetine Hydrochloride; Female; Isotretinoin; Motor Activity; Rats; Rats, Sprague-Dawley; Rats, Wistar; Urinary Bladder, Overactive; Urodynamics | 2018 |
Comparative efficacy and acceptability of antidepressant treatment in poststroke depression: a multiple-treatments meta-analysis.
Topics: Aged; Antidepressive Agents; Antidepressive Agents, Second-Generation; Citalopram; Depression; Depressive Disorder; Doxepin; Duloxetine Hydrochloride; Female; Fluoxetine; Humans; Male; Morpholines; Paroxetine; Patient Acceptance of Health Care; Reboxetine; Selective Serotonin Reuptake Inhibitors; Stroke; Treatment Outcome | 2017 |
A standardization of the Novelty-Suppressed Feeding Test protocol in rats.
Topics: Animals; Antidepressive Agents; Depression; Depressive Disorder; Disease Models, Animal; Duloxetine Hydrochloride; Exploratory Behavior; Male; Rats, Sprague-Dawley; Reproducibility of Results; Reserpine | 2017 |
Duloxetine loaded-microemulsion system to improve behavioral activities by upregulating serotonin and norepinephrine in brain for the treatment of depression.
Topics: Animals; Behavior, Animal; Biological Availability; Brain; Depression; Disease Models, Animal; Duloxetine Hydrochloride; Duodenum; Emulsions; Norepinephrine; Pharmaceutical Preparations; Rats; Serotonin; Serotonin and Noradrenaline Reuptake Inhibitors; Up-Regulation | 2018 |
Effects of Magnesium Oxide on the Serum Duloxetine Concentration and Antidepressant-Like Effects of Duloxetine in Rats.
Topics: Animals; Antidepressive Agents; Chromatography, High Pressure Liquid; Constipation; Depression; Drug Interactions; Duloxetine Hydrochloride; Magnesium Oxide; Male; Norepinephrine; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin; Swimming; Thiophenes | 2018 |
Clinical characteristic and fecal microbiota responses to probiotic or antidepressant in patients with diarrhea-predominant irritable bowel syndrome with depression comorbidity: a pilot study.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Body Mass Index; Depression; Diarrhea; Duloxetine Hydrochloride; Feces; Humans; Irritable Bowel Syndrome; Middle Aged; Pilot Projects; Probiotics; RNA, Ribosomal, 16S; Young Adult | 2019 |
Levomilnacipran (F2695), a norepinephrine-preferring SNRI: profile in vitro and in models of depression and anxiety.
Topics: Adrenergic Uptake Inhibitors; Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Behavior, Animal; Cerebral Cortex; Cyclohexanols; Cyclopropanes; Depression; Dopamine; Duloxetine Hydrochloride; Humans; Male; Mice; Milnacipran; Motor Activity; Neurotransmitter Transport Proteins; Norepinephrine; Rats; Serotonin; Synaptosomes; Thiophenes; Venlafaxine Hydrochloride | 2013 |
Prescribing patterns and safety monitoring of duloxetine using the Danish Register of Medicinal Product Statistics as a source.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Child; Child, Preschool; Denmark; Depression; Drug Monitoring; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Practice Patterns, Physicians'; Registries; Retrospective Studies; Thiophenes; Young Adult | 2013 |
[Duloxetine for chronic pain management: pharmacology and clinical use].
Topics: Adrenergic Uptake Inhibitors; Chronic Pain; Depression; Depressive Disorder; Diabetic Neuropathies; Duloxetine Hydrochloride; Humans; Thiophenes | 2013 |
Prenatal antidepressant exposure and risk of spontaneous abortion - a population-based study.
Topics: Abortion, Spontaneous; Adult; Antidepressive Agents; Cyclohexanols; Depression; Duloxetine Hydrochloride; Female; Humans; Maternal-Fetal Exchange; Mianserin; Mirtazapine; Pregnancy; Risk; Risk Assessment; Selective Serotonin Reuptake Inhibitors; Thiophenes; Venlafaxine Hydrochloride; Young Adult | 2013 |
Duloxetine prophylaxis for episodic migraine in persons without depression: a prospective study.
Topics: Adult; Antidepressive Agents; Depression; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Migraine Disorders; Pilot Projects; Prospective Studies; Thiophenes; Young Adult | 2013 |
Duloxetine-related galactorrhea and restless legs syndrome: a case report.
Topics: Antidepressive Agents; Depression; Duloxetine Hydrochloride; Female; Galactorrhea; Humans; Middle Aged; Restless Legs Syndrome; Thiophenes | 2013 |
Long-term duloxetine withdrawal syndrome and management in a depressed patient.
Topics: Antidepressive Agents; Depression; Duloxetine Hydrochloride; Female; Humans; Substance Withdrawal Syndrome; Thiophenes | 2014 |
Individual residual symptoms and functional impairment in patients with depression.
Topics: Adult; Antidepressive Agents; Anxiety; Depression; Depressive Disorder, Major; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Pain; Sleep Wake Disorders; Thiophenes | 2014 |
The safety of duloxetine during pregnancy and lactation.
Topics: Antidepressive Agents; Depression; Drug Administration Schedule; Duloxetine Hydrochloride; Female; Humans; Infant; Lactation; Milk, Human; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects; Thiophenes | 2014 |
Hepatic outcomes among adults taking duloxetine: a retrospective cohort study in a US health care claims database.
Topics: Adolescent; Adult; Aged; Chemical and Drug Induced Liver Injury; Databases, Factual; Depression; Drug Utilization Review; Duloxetine Hydrochloride; Female; Humans; Incidence; Insurance, Health; Male; Middle Aged; Propensity Score; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; United States; Venlafaxine Hydrochloride; Young Adult | 2015 |
Comprehensive Duloxetine Analysis in a Fatal Overdose.
Topics: Aged; Alcoholism; Amitriptyline; Depression; Diphenhydramine; Drug Overdose; Duloxetine Hydrochloride; Fatal Outcome; Female; Humans; Selective Serotonin Reuptake Inhibitors | 2016 |
Effects of duloxetine on microRNA expression profile in frontal lobe and hippocampus in a mouse model of depression.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Depression; Disease Models, Animal; Duloxetine Hydrochloride; Food Preferences; Frontal Lobe; Gene Expression Profiling; Gene Expression Regulation; Hippocampus; Male; Mice; MicroRNAs; Motor Activity; Oligonucleotide Array Sequence Analysis; Time Factors | 2015 |
Duloxetine and 8-OH-DPAT, but not fluoxetine, reduce depression-like behaviour in an animal model of chronic neuropathic pain.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenergic Neurons; Analgesics; Animals; Antidepressive Agents; Behavior, Animal; Chronic Disease; Depression; Duloxetine Hydrochloride; Fluoxetine; Hyperalgesia; Male; Neuralgia; Norepinephrine; Rats, Wistar; Serotonergic Neurons; Serotonin | 2016 |
Antidepressant-like Effects of ZBH2012001, a Novel Potent Serotonin and Norepinephrine Reuptake Inhibitor.
Topics: Analysis of Variance; Animals; Antidepressive Agents; Benzodioxoles; Calcium; Cyclic AMP; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Duloxetine Hydrochloride; HEK293 Cells; Helplessness, Learned; Hindlimb Suspension; Humans; Inhibitory Concentration 50; Locomotion; Male; Mice; Mice, Inbred ICR; Protein Binding; Rats; Rats, Sprague-Dawley; Serotonin and Noradrenaline Reuptake Inhibitors; Swimming; Thiophenes | 2016 |
Duloxetine-related posterior reversible encephalopathy syndrome: A case report.
Topics: Aged, 80 and over; Antidepressive Agents; Depression; Duloxetine Hydrochloride; Female; Humans; Neuroimaging; Posterior Leukoencephalopathy Syndrome; Tomography, X-Ray Computed | 2016 |
Distinct Antidepressant-Like and Cognitive Effects of Antidepressants with Different Mechanisms of Action in Middle-Aged Female Mice.
Topics: Aging; Animals; Antidepressive Agents; Cognition; Cohort Studies; Depression; Duloxetine Hydrochloride; Female; Fluoxetine; Memory; Mice, Inbred C57BL; Piperazines; Psychotropic Drugs; Random Allocation; Space Perception; Sulfides; Vilazodone Hydrochloride; Visual Perception; Vortioxetine | 2017 |
Pharmacokinetic profiles contribute to the differences in behavioral pharmacology of 071031B enantiomers as novel serotonin and norepinephrine reuptake inhibitors.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Benzodioxoles; Depression; Depressive Disorder; Duloxetine Hydrochloride; Male; Mice; Mice, Inbred ICR; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin and Noradrenaline Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Swimming; Thiophenes | 2017 |
Serious suicide attempt with duloxetine treatment.
Topics: Depression; Duloxetine Hydrochloride; Humans; Male; Middle Aged; Neck Pain; Selective Serotonin Reuptake Inhibitors; Suicide, Attempted; Thiophenes | 2008 |
Serotonin-Norepinephrine Reuptake Inhibitor (SNRI) treatment for Isaacs syndrome with depression.
Topics: Adult; Depression; Duloxetine Hydrochloride; Humans; Isaacs Syndrome; Male; Selective Serotonin Reuptake Inhibitors; Thiophenes | 2009 |
Cooperative opioid and serotonergic mechanisms generate superior antidepressant-like effects in a mice model of depression.
Topics: Analgesics, Opioid; Animals; Antidepressive Agents; Behavior, Animal; Codeine; Depression; Desipramine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Duloxetine Hydrochloride; Enzyme Inhibitors; Hindlimb Suspension; Male; Mice; Motor Activity; Selective Serotonin Reuptake Inhibitors; Serotonin; Thiophenes; Tramadol | 2009 |
Antidepressant-associated myoclonic status in a patient with symptomatic generalized epilepsy: does risk occur with therapeutic doses?
Topics: Antidepressive Agents; Depression; Duloxetine Hydrochloride; Electroencephalography; Epilepsy, Generalized; Humans; Male; Middle Aged; Paroxetine; Seizures; Thiophenes | 2009 |
Duloxetine related binge eating behaviors: a case report.
Topics: Adult; Antidepressive Agents; Binge-Eating Disorder; Depression; Duloxetine Hydrochloride; Female; Humans; Thiophenes | 2009 |
Evaluation of anti-obesity activity of duloxetine in comparison with sibutramine along with its anti-depressant activity: an experimental study in obese rats.
Topics: Adiposity; Animals; Anti-Obesity Agents; Antidepressive Agents; Appetite Regulation; Blood Pressure; Body Temperature Regulation; Body Weight; Cyclobutanes; Depression; Diet; Drug Evaluation, Preclinical; Drug Therapy, Combination; Duloxetine Hydrochloride; Male; Motor Activity; Obesity; Rats; Rats, Sprague-Dawley; Satiety Response; Selective Serotonin Reuptake Inhibitors; Thiophenes | 2009 |
Recurrent episodes of serotonin-reuptake inhibitor-mediated hyponatremia in an elderly patient.
Topics: Aged; Antidepressive Agents; Depression; Dose-Response Relationship, Drug; Duloxetine Hydrochloride; Female; Humans; Inappropriate ADH Syndrome; Recurrence; Selective Serotonin Reuptake Inhibitors; Sodium; Thiophenes | 2009 |
Increased aripiprazole concentrations in an HIV-positive male concurrently taking duloxetine, darunavir, and ritonavir.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Anxiety; Aripiprazole; Cytochrome P-450 Enzyme Inhibitors; Darunavir; Depression; Dose-Response Relationship, Drug; Duloxetine Hydrochloride; HIV Infections; HIV Protease Inhibitors; Humans; Male; Piperazines; Quinolones; Ritonavir; Sulfonamides; Thiophenes | 2010 |
Pathologic grooming behavior: facial dermatillomania.
Topics: Binge-Eating Disorder; Body Dysmorphic Disorders; Cognitive Behavioral Therapy; Depression; Disruptive, Impulse Control, and Conduct Disorders; Duloxetine Hydrochloride; Exercise; Face; Female; Hair; Humans; Middle Aged; Selective Serotonin Reuptake Inhibitors; Skin Care; Thiophenes | 2011 |
Duloxetine. Also avoid its use in recurrent depression.
Topics: Antidepressive Agents; Depression; Duloxetine Hydrochloride; Humans; Recurrence; Thiophenes | 2010 |
Duloxetine for depression and the incidence of hepatic events in adults.
Topics: Adolescent; Adult; Chemical and Drug Induced Liver Injury; Cohort Studies; Depression; Duloxetine Hydrochloride; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Retrospective Studies; Thiophenes; Young Adult | 2011 |
Electroretinographic assessment in major depressed patients receiving duloxetine: might differences between responders and non-responders indicate a differential biological background?
Topics: Adult; Antidepressive Agents; Case-Control Studies; Depression; Depressive Disorder; Depressive Disorder, Major; Dopamine; Duloxetine Hydrochloride; Electroretinography; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Sample Size; Thiophenes; Treatment Outcome | 2011 |
Colleague interactions and new drug prescribing behavior: the case of the initial prescription of antidepressants in Taiwanese medical centers.
Topics: Adult; Antidepressive Agents; Depression; Duloxetine Hydrochloride; Female; Humans; Interprofessional Relations; Interviews as Topic; Male; Middle Aged; Practice Patterns, Physicians'; Prescription Drugs; Proportional Hazards Models; Psychiatry; Taiwan; Thiophenes; Young Adult | 2011 |
Inhibition of G protein-activated inwardly rectifying K+ channels by different classes of antidepressants.
Topics: Amoxapine; Animals; Antidepressive Agents; Depression; Dose-Response Relationship, Drug; Duloxetine Hydrochloride; Ethanol; Female; GTP-Binding Proteins; Humans; Mice; Oocytes; Potassium Channels; RNA, Messenger; Sertraline; Thiophenes; Xenopus laevis | 2011 |
Duloxetine HCl lipid nanoparticles: preparation, characterization, and dosage form design.
Topics: Animals; Antidepressive Agents; Depression; Dosage Forms; Drug Design; Duloxetine Hydrochloride; Lipids; Male; Mice; Nanoparticles; Particle Size; Thiophenes; X-Ray Diffraction | 2012 |
Selective serotonin reuptake inhibitors, venlafaxine and duloxetine are associated with in hospital morbidity but not bleeding or late mortality after coronary artery bypass graft surgery.
Topics: Aged; Aged, 80 and over; Australia; Coronary Artery Bypass; Coronary Artery Disease; Cyclohexanols; Depression; Duloxetine Hydrochloride; Female; Follow-Up Studies; Hospital Mortality; Humans; Kidney Diseases; Male; Middle Aged; Postoperative Hemorrhage; Proportional Hazards Models; Renal Dialysis; Respiration, Artificial; Selective Serotonin Reuptake Inhibitors; Thiophenes; Time Factors; Venlafaxine Hydrochloride | 2012 |
Tolerability aspects in duloxetine-treated patients with depression: Should one use a lower starting dose in clinical practice?
Topics: Adult; Aged; Analgesics; Antidepressive Agents; Depression; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Interactions; Drug Monitoring; Drug Tolerance; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Pain; Precision Medicine; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Thiophenes | 2012 |
Development of microscopic colitis secondary to duloxetine.
Topics: Aged; Antidepressive Agents; Colitis, Microscopic; Depression; Duloxetine Hydrochloride; Female; Humans; Remission, Spontaneous; Thiophenes | 2013 |
Use of antidepressants for depression in patients with Parkinson's disease.
Topics: Antidepressive Agents; Depression; Duloxetine Hydrochloride; Humans; Parkinson Disease; Positron-Emission Tomography; Thiophenes | 2013 |
Duloxetine (Cymbalta): a new SNRI for depression.
Topics: Administration, Oral; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2D6; Depression; Drug Interactions; Duloxetine Hydrochloride; Half-Life; Humans; Liver; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Thiophenes | 2004 |
Duloxetine associated with smoking cessation.
Topics: Adult; Depression; Duloxetine Hydrochloride; Humans; Male; Selective Serotonin Reuptake Inhibitors; Smoking Cessation; Thiophenes | 2005 |
Duloxetine-induced syndrome of inappropriate antidiuretic hormone secretion and seizures.
Topics: Antidepressive Agents; Depression; Drug Administration Schedule; Duloxetine Hydrochloride; Female; Humans; Inappropriate ADH Syndrome; Medical Errors; Middle Aged; Seizures; Thiophenes; Treatment Outcome | 2006 |
Planning and analysis of three-arm non-inferiority trials with binary endpoints.
Topics: Controlled Clinical Trials as Topic; Data Interpretation, Statistical; Depression; Duloxetine Hydrochloride; Humans; Paroxetine; Research Design; Sample Size; Selective Serotonin Reuptake Inhibitors; Statistics as Topic; Therapeutic Equivalency; Thiophenes | 2007 |
Duloxetine treatment of stress urinary incontinence in women: effects of demographics, obesity, chronic lung disease, hypoestrogenism, diabetes mellitus, and depression on efficacy.
Topics: Adult; Aged; Aged, 80 and over; Chronic Disease; Comorbidity; Controlled Clinical Trials as Topic; Demography; Depression; Diabetes Mellitus; Duloxetine Hydrochloride; Estrogens; Female; Humans; Lung Diseases; Middle Aged; Obesity; Thiophenes; Treatment Outcome; Urinary Incontinence, Stress | 2007 |
[Physical complaints can overlap mental symptoms. Diffuse pain? Think about depression!].
Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Depression; Diagnosis, Differential; Duloxetine Hydrochloride; Female; Humans; Male; Pain; Recurrence; Remission Induction; Selective Serotonin Reuptake Inhibitors; Thiophenes; Time Factors | 2006 |
[Duloxetin effective in depression and pain: high remission rates obtained].
Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Clinical Trials as Topic; Depression; Dopamine Uptake Inhibitors; Duloxetine Hydrochloride; Humans; Pain; Pain Measurement; Placebos; Psychiatric Status Rating Scales; Remission Induction; Selective Serotonin Reuptake Inhibitors; Thiophenes; Time Factors | 2006 |
Serotonin syndrome precipitated by linezolid in a medically ill patient on duloxetine.
Topics: Acetamides; Anti-Infective Agents; Antidepressive Agents; Depression; Drug Interactions; Duloxetine Hydrochloride; Female; Humans; Linezolid; Middle Aged; Monoamine Oxidase Inhibitors; Oxazolidinones; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Surgical Wound Dehiscence; Thiophenes | 2006 |
Recurrent hyponatremia after substitution of citalopram with duloxetine.
Topics: Aged, 80 and over; Antidepressive Agents, Tricyclic; Citalopram; Depression; Duloxetine Hydrochloride; Female; Humans; Hyponatremia; Nortriptyline; Recurrence; Selective Serotonin Reuptake Inhibitors; Thiophenes | 2007 |
HPLC analysis of the novel antidepressant duloxetine in human plasma after an original solid-phase extraction procedure.
Topics: Antidepressive Agents; Calibration; Chromatography, High Pressure Liquid; Depression; Duloxetine Hydrochloride; Humans; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Thiophenes | 2007 |